SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Phillips 66 PSX Western Gateway Pipeline Partnership Expands Refined Products Footprint in HighDemand US Southwest Markets Regeneron Pharmaceuticals REGN Unveils C5 Complement Pipeline Strategy But Execution Risks Cap NearTerm Upside